7/2/2013 8:08:19 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Stockholm, July 2, 2013. Based on the authorization from the 2013 Annual General
Meeting, the Board of Moberg Pharma AB (OMX: MOB)(“Moberg Pharma”, the “Company”
or the “Group”) has resolved to issue new shares with deviation from the
shareholders’ preferential rights to Bure Equity AB (publ) (“Bure”). The purpose
of the financing is to facilitate forthcoming additions to the Company´s product
Help employers find you! Check out all the jobs and post your resume.
comments powered by